458 related articles for article (PubMed ID: 25335723)
1. [Adjuvant therapy with WT1 peptide-pulsed dendritic cell therapy in combination with TS-1 for pancreatic cancer with positive peritoneal cytology after curative operation].
Hashimoto K; Tono T; Abe H; Nishida K; Yanagawa T; Fujie Y; Fujita S; Fujita J; Yoshida T; Ohnishi T; Imaoka S; Monden T
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1298-300. PubMed ID: 25335723
[TBL] [Abstract][Full Text] [Related]
2. [A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer].
Miyamoto T; Inoue M; Tanemura M; Yamaguchi M; Irei T; Tamaru K; Seo S; Misumi T; Shimizu W; Suzuki T; Onoe T; Sudo T; Shimizu Y; Hinoi T; Tashiro H
Gan To Kagaku Ryoho; 2018 Jan; 45(1):88-90. PubMed ID: 29362317
[TBL] [Abstract][Full Text] [Related]
3. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
[TBL] [Abstract][Full Text] [Related]
4. [R0 Resection by Distal Pancreatectomy with En Bloc Celiac Axis Resection after Down-Staging by FOLFIRINOX Therapy in a Case of Pancreas Cancer--Report of a Case].
Makino H; Kametaka H; Fukada T; Seike K; Koyama T; Hasegawa A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1644-6. PubMed ID: 26805124
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
[TBL] [Abstract][Full Text] [Related]
6. WT1 peptide vaccine stabilized intractable ovarian cancer patient for one year: a case report.
Dohi S; Ohno S; Ohno Y; Takakura M; Kyo S; Soma G; Sugiyama H; Inoue M
Anticancer Res; 2011 Jul; 31(7):2441-5. PubMed ID: 21873157
[TBL] [Abstract][Full Text] [Related]
7. [A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy].
Koga C; Tanemura M; Wada H; Kobayashi S; Marubashi S; Eguchi H; Mori M; Doki Y; Nagano H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2454-6. PubMed ID: 22202411
[TBL] [Abstract][Full Text] [Related]
8. Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1.
Ito Z; Kan S; Bito T; Horiuchi S; Akasu T; Yoshida S; Kajihara M; Hokari A; Saruta M; Yoshida N; Kobayashi M; Ohkusa T; Shimodaira S; Okamoto M; Sugiyama H; Koido S
Oncology; 2019; 97(3):135-148. PubMed ID: 31216557
[TBL] [Abstract][Full Text] [Related]
9. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Intestinal Obstruction Caused by Peritoneal Metastatic Recurrence One Year after Radical Operation for Pancreatic Cancer].
Ota H; Yokoyama S; Honda S; Ito K; Miyazaki H; Ueda H; Takiguchi N; Nakai S; Matsuno H; Takeoka T; Konishi K; Okada K; Fukunaga M; Kobayashi K
Gan To Kagaku Ryoho; 2020 Apr; 47(4):718-721. PubMed ID: 32389995
[TBL] [Abstract][Full Text] [Related]
11. WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study.
Yanagisawa R; Koizumi T; Koya T; Sano K; Koido S; Nagai K; Kobayashi M; Okamoto M; Sugiyama H; Shimodaira S
Anticancer Res; 2018 Apr; 38(4):2217-2225. PubMed ID: 29599342
[TBL] [Abstract][Full Text] [Related]
12. Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer.
Mayanagi S; Kitago M; Sakurai T; Matsuda T; Fujita T; Higuchi H; Taguchi J; Takeuchi H; Itano O; Aiura K; Hamamoto Y; Takaishi H; Okamoto M; Sunamura M; Kawakami Y; Kitagawa Y
Cancer Sci; 2015 Apr; 106(4):397-406. PubMed ID: 25614082
[TBL] [Abstract][Full Text] [Related]
13. Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia.
Kitawaki T; Kadowaki N; Kondo T; Ishikawa T; Ichinohe T; Teramukai S; Fukushima M; Kasai Y; Maekawa T; Uchiyama T
Am J Hematol; 2008 Apr; 83(4):315-7. PubMed ID: 18081032
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of WT1 peptide-/MUC-1 peptide-pulsed dendritic cell therapy in 313 patients with a wide range of cancers].
Kato Y
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1280-2. PubMed ID: 25335717
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced gastric cancer with invasion of pancreas effectively treated by combined chemotherapy of TS-1 and paclitaxel (TXL)].
Ohchi T; Kudo S; Ogata K; Nakamura T; Koga Y; Ishiodori H; Ochiai T; Ishihara A
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1637-41. PubMed ID: 12355952
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines.
Hanada S; Tsuruta T; Haraguchi K; Okamoto M; Sugiyama H; Koido S
Hum Vaccin Immunother; 2019; 15(2):397-406. PubMed ID: 30230959
[TBL] [Abstract][Full Text] [Related]
17. [A case of scirrhous gastric cancer with peritoneal metastases successfully treated by combined chemotherapy of biweekly paclitaxel and TS-1 followed by curative resection].
Yoshida K; Yamaguchi S; Kawaguchi A
Gan To Kagaku Ryoho; 2007 Apr; 34(4):601-4. PubMed ID: 17431348
[TBL] [Abstract][Full Text] [Related]
18. Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma.
Coosemans A; Wölfl M; Berneman ZN; Van Tendeloo V; Vergote I; Amant F; Van Gool SW
Anticancer Res; 2010 Sep; 30(9):3709-14. PubMed ID: 20944158
[TBL] [Abstract][Full Text] [Related]
19. [Long-term survival following postoperative combined modality therapy for pancreatic cancer].
Miyazawa K; Yoshioka S; Shiobara M; Wakatsuki K; Kataoka M; Arai S; Yamazaki K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2190-2. PubMed ID: 25731466
[TBL] [Abstract][Full Text] [Related]
20. Value of peritoneal cytology in potentially resectable pancreatic cancer.
Yamada S; Fujii T; Kanda M; Sugimoto H; Nomoto S; Takeda S; Nakao A; Kodera Y
Br J Surg; 2013 Dec; 100(13):1791-6. PubMed ID: 24227366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
